Full text

Turn on search term navigation

© 2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background

While there is increasing interest in sharing genetic research results with participants, how best to communicate the risks, benefits and limitations of research results remains unclear.

Methods

Participants who received genetic research results answered open and closed‐ended questions about their experiences receiving results and interest in and advantages and disadvantages of a web‐based alternative to genetic counseling.

Results

107 BRCA1/2 negative women with a personal or family history of breast cancer consented to receive genetic research results and 82% completed survey items about their experience. Most participants reported there was nothing they disliked (74%) or would change (85%) about their predisclosure or disclosure session (78% and 89%). They most frequently reported liking the genetic counselor and learning new information. Only 24% and 26% would not be willing to complete predisclosure counseling or disclosure of results by a web‐based alternative, respectively. The most frequently reported advantages included convenience and reduced time. Disadvantages included not being able to ask questions, the risk of misunderstanding and the impersonal nature of the encounter.

Conclusion

Most participants receiving genetic research results report high satisfaction with telephone genetic counseling, but some may be willing to consider self‐directed web alternatives for both predisclosure genetic education and return of results.

Details

Title
Research participants’ experiences with return of genetic research results and preferences for web‐based alternatives
Author
Gaieski, Jill B 1   VIAFID ORCID Logo  ; Linda Patrick‐Miller 2 ; Egleston, Brian L 3 ; Maxwell, Kara N 1 ; Walser, Sarah 1 ; DiGiovanni, Laura 4 ; Brower, Jamie 4 ; Fetzer, Dominique 1 ; Ganzak, Amanda 1 ; McKenna, Danielle 1 ; Long, Jessica M 1 ; Powers, Jacquelyn 1 ; Stopfer, Jill E 4 ; Nathanson, Katherine L 5 ; Domchek, Susan M 6 ; Bradbury, Angela R 7   VIAFID ORCID Logo 

 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA 
 Department of Medicine, Division of Hematology‐Oncology, The University of Chicago, Chicago, USA; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, USA 
 Fox Chase Cancer Center, Temple University Health System, Philadelphia, USA 
 Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA 
 Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Basser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 
 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Basser Center for BRCA, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 
 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA 
Section
ORIGINAL ARTICLES
Publication year
2019
Publication date
Sep 2019
Publisher
John Wiley & Sons, Inc.
e-ISSN
23249269
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2287019079
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.